Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Aarhus N
Clinical trial register · Denmark

Clinical Trials in Aarhus N, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Aarhus39 Aarhus University Hospital26 AstraZeneca17 Hoffmann-La Roche16 Novo Nordisk A/S13
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Aarhus N

205 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Aabenraa, Aarhus N, Herlev, Herning, Hvidovre, Kolding
2026-10-26
Not yet open
Novo Nordisk A/S
Phase 3
84
Aarhus N
2026-10-09
Not yet open
IRONCARE: Iron Treatment in Older Patients With Hip Fractures
NCT07659184Hip Fracture, Anemia, Iron, Placebo - Control
DrugsIron·Ferric Derisomaltose
University of Aarhus
Phase 4
528
Aarhus N, Herning, Horsens, Randers, Viborg
2026-10-01
Not yet open
Aarhus University Hospital
Not applicable
182
Copenhagen, Aalborg, Aarhus N, Odense
2026-09-01
Recruiting
AstraZeneca
Phase 3
500
Aarhus N, Gandrup, Herlev, Holbæk, Hvidovre, Middelfart, Odense, Vejle
2026-08-24
Recruiting
Novo Nordisk A/S
Phase 3
450
Aarhus N, Hellerup, Herning
2026-08-12
Recruiting
Eli Lilly and Company
Phase 4
14
Aarhus N, Slagelse
2026-08-05
Recruiting
Novo Nordisk A/S
Phase 1
120
Aarhus N
2026-08-03
Recruiting
Boehringer Ingelheim
Phase 3
35
Aarhus N
2026-07-21
Recruiting
Boehringer Ingelheim
Phase 3
390
Aarhus N, Copenhagen, Odense C
2026-07-10
Recruiting
AstraZeneca
Phase 3
900
Aarhus N, Gistrup, Herlev, Hillerød, Holbæk, Hvidovre
2026-07-06
Recruiting
AstraZeneca
Phase 3
2,000
Aarhus N, Esbjerg, Gandrup, Herlev, Hillerød, Hvidovre, Odense
2026-07-06
Recruiting
Central Denmark Region
Observational
500
Aarhus N
2026-07-01
Not yet open
Aarhus University Hospital
Not applicable
15
Aarhus N, Horsens, Viborg
2026-07
Recruiting
The Pre-POCT-Non-Conveyance Trial: Prehospital Point-of-Care Testing to Support Non-Conveyance Decisions
NCT07503470Prehospital Emergency Medical Services, Prehospital Emergency Care, Point of Care Testing
Central Denmark Region
Not applicable
1,500
Aarhus N
2026-05-26
Recruiting
Biosense Webster, Inc.
Not applicable
50
Aarhus N
2026-05-19
Recruiting
Janssen Research & Development, LLC
Phase 1
360
Aarhus N
2026-05-13
Recruiting
Wrist Injury Strengthening Exercise (WISE) Versus Usual Care Advice for Improving Pain and Function
NCT07538323Distal Radius Fracture, Colles Fracture, Wrist Fracture, Wrist Fractures
University of Aarhus
Not applicable
588
Aarhus N
2026-05-12
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Aarhus N, Copenhagen, Esbjerg, Gistrup, Herlev, Roskilde, Viborg
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
400
Aarhus N, Frederiksberg, Herlev
2026-04-20
Recruiting
Novo Nordisk A/S
Phase 3
400
Aarhus N, Frederiksberg, Herlev
2026-04-13
Recruiting
Novo Nordisk A/S
Phase 1
100
Aarhus N
2026-04-10
Recruiting
Biosense Webster, Inc.
Not applicable
50
Aarhus N
2026-03-23
Recruiting
Aarhus University Hospital
Observational
500
Aarhus N
2026-03-17
Recruiting
University of Aarhus
Observational
600
Aarhus N, Odense, Randers
2026-02-24
Recruiting
The Metabolic Effects of Oral Tributyrin Administration
NCT07463495Healthy Overweight/Obese
University of Aarhus
Not applicable
12
Aarhus N
2026-02-20
Recruiting
AstraZeneca
Phase 2
124
Aarhus N, Gistrup, Hvidovre
2026-02-10
Not yet open
Reversal to Normoglycemia by Treating Prediabetes
NCT07392151Prediabetes, Chronic Coronary Syndrome
Michael Mæng
Phase 3
158
Aarhus N
2026-02
Recruiting
Insmed Incorporated
Phase 3
344
Aarhus N
2026-01-07
By invitation
The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.
NCT07347392Non-Melanoma Skin Cancer (NMSC), Basal Cell Carcinoma of Skin, Squamous Cell Carcinoma of the Skin
University of Aarhus
Observational
2,900
Aarhus N
2025-12-15
Recruiting
AstraZeneca
Phase 2
230
Aarhus N, Gistrup, Hvidovre, København Ø, Odense C
2025-12-10
Recruiting
Effects of Ketone Bodies on Insulin Sensitivity
NCT07359625Insulin Resistance, Obesity & Overweight, Energy Metabolism, Ketone Body Metabolism
University of Aarhus
Not applicable
10
Aarhus N
2025-12-02
By invitation
University of Aarhus
Not applicable
13
Aarhus N
2025-12-01
Recruiting
Hoffmann-La Roche
Phase 3
250
Aarhus N, Glostrup Municipality
2025-11-27
Recruiting
Zealand University Hospital
Observational
2,500
Aarhus N, Herlev, København Ø, Roskilde
2025-11-26
By invitation
Celldex Therapeutics
Phase 3
1,370
Aarhus N, Hellerup
2025-11-25
Recruiting
Hoffmann-La Roche
Phase 3
900
Aarhus N, Herning, København NV
2025-11-24
By invitation
Optical Coherence Tomography in Acute Vessel Evaluation
NCT07422688Ischemic Heart Disease, Ischemic Coronary Artery Disease, ACS (Acute Coronary Syndrome)
Aarhus University Hospital Skejby
Not applicable
3,000
Aalborg, Aarhus N, København Ø, Odense, Roskilde
2025-11-23
Recruiting
Aarhus University Hospital
Phase 2
150
Aarhus N
2025-11-12
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Aalborg, Aarhus N, København Ø
2025-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Aarhus N, Esbjerg, Glostrup Municipality, Odense C
2025-11-11
Recruiting
AstraZeneca
Phase 2
435
Aalborg, Aarhus N, Hvidovre, Odense C, Roskilde
2025-11-06
Recruiting
Mads Ryo Jochumsen
Not applicable
100
Aarhus N, Herning
2025-11-03
Recruiting
Magnesium in Gastrointestinal Disease
NCT07338565Colitis Ulcerosa, Colitis Ulcerative, Crohns Disease, Morbus Crohn
University of Aarhus
Observational
120
Aarhus N
2025-11-03
Recruiting
The MICRON Study - A Steno 1 Substudy
NCT07270172Type 1 Diabetes Mellitus
University of Aarhus
Observational
40
Aarhus N, Gødstrup, Horsens, Silkeborg, Viborg
2025-10-27
Recruiting
Hoffmann-La Roche
Phase 3
600
Køge, Aarhus N, Herlev, København Ø, Sønderborg
2025-10-24
Active, closed
Developing Competency Awareness and Clinical Coordination in a Neonatal Unit
NCT07423468Neonatal Care, Burnout, Professional, Psychological Safety, Interprofessional Relations
University of Aarhus
Not applicable
160
Aarhus N
2025-10-01
Recruiting
Pfizer
Phase 3
680
Copenhagen, Roskilde, Odense, Aarhus N
2025-09-29
Recruiting
Fluorescence-Guided Optimization of Sarcoma Margins
NCT07134192Soft Tissue Sarcoma of the Trunk and Extremities, Sarcoma
University of Aarhus
Not applicable
90
Aarhus N, Copenhagen
2025-09-01
Recruiting
Aarhus University Hospital
Not applicable
800
Aarhus N
2025-08-15
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Aalborg, Aarhus N, Copenhagen, Odense, Roskilde
2025-08-05
Recruiting
Microenvironment in Patients Undergoing Non-traumatic Amputation
NCT07384689Lower Limb Amputation Above Knee
University of Aarhus
Not applicable
20
Aarhus N
2025-08-01
Recruiting
Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
NCT06714123Pulmonary Fibrosis, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis
DrugSenicapoc
Vejle Hospital
Phase 2
140
Aarhus N, Copenhagen
2025-08-01
Recruiting
Amgen
Phase 3
12,800
Aalborg, Aarhus N, Esbjerg, Gandrup, Herlev, Herning, Holbæk, Hvidovre
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Aarhus N, Esbjerg, Herlev, Herning, Hvidovre, Kolding, Slagelse
2025-07-22
Active, closed
ViiV Healthcare
Phase 1
107
Hvidovre, Aarhus N
2025-07-10
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Aalborg, Aarhus N, København Ø
2025-07-02
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Aarhus N, København Ø, Odense C
2025-07-02
Recruiting
Progressive Resistance Training for Adults With External Snapping Hip
NCT06924164External Snapping Hip, Coxa Saltans External
Aarhus University Hospital
Not applicable
100
Aalborg, Aarhus N, Copenhagen, Herning, Hillerød, Horsens, Hvidovre, Køge
2025-07-01
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Aarhus N, Esbjerg, Frederiksberg, Herlev, Herning, Hvidovre, Roskilde
2025-06-25
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Aarhus N, Glostrup Municipality
2025-06-23
Recruiting
New Methods for Evaluating Preventive Migraine Treatment
NCT07071506Migraine, Migraine With or Without Aura, Headache Disorders, Chronic Migraine, Headache
University of Aarhus
Not applicable
60
Aarhus C, Aarhus N
2025-06-19
Recruiting
The SWEEP Trial: a Randomized Controlled Trial
NCT07043088Membrane Stripping, Cervical Ripening, Memrane Sweeping
University of Aarhus
Not applicable
1,536
Aarhus N
2025-06-18
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Aarhus N, Copenhagen, Esbjerg, Herlev, Herning, Hvidovre, Viborg
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Aalborg, Aarhus N, Hvidovre, København Ø, Vejle
2025-06-09
Recruiting
AstraZeneca
Phase 3
15,100
Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gandrup, Gistrup, Herlev, Herning
2025-06-04
Recruiting
Central Denmark Region
Phase 4
1,888
Aarhus N
2025-06-02
Recruiting
Jakob Kristian Jakobsen
Phase 4
272
Aalborg, Aarhus N, Herlev, Roskilde
2025-06-01
Recruiting
Early WAKE-up Predictors After Out-of-Hospital Cardiac Arrest
NCT06979700Cardiac Arrest (CA), Anoxic Brain Injury, Comatose Survivors of Cardiac Arrest, EEG
University of Aarhus
Observational
250
Aarhus N, Copenhagen
2025-05-13
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Aalborg, Aarhus N, Copenhagen, Odense
2025-05-05
Recruiting
Takeda
Observational
30
Aarhus N, København Ø
2025-04-29
Recruiting
University of Aarhus
Observational
120
Aarhus N, Odense, Randers
2025-04-15
Recruiting
University of Aarhus
Phase 4
90
Aarhus N
2025-03-21
Recruiting
Aarhus University Hospital
Phase 2
250
Aalborg, Aarhus N, Copenhagen, Herning, Hvidovre, Odense, Viborg
2025-03-20
Recruiting
Lars Wiuff Andersen
Not applicable
909
Aalborg, Aarhus N, Ballerup Municipality, Næstved, Vejle
2025-03-15
Recruiting
AstraZeneca
Phase 3
11,300
Aarhus, Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gistrup, Herlev, Herning
2025-03-14
Active, closed
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
NCT06592586Streptococcus Agalactiae Infection, Neonatal Sepsis, Pneumonia, Meningitis
Minervax ApS
Phase 2/3
137
Copenhagen, Aarhus N, Kolding
2025-03-07
By invitation
University of Aarhus
Observational
1,200
Aarhus N
2025-03-05
Recruiting
University of Aarhus
Phase 4
140
Aarhus N
2025-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Aarhus N, Esbjerg, Frederiksberg, Herning, Svendborg, Vejle
2025-02-21
Recruiting
Bayer
Phase 2
111
Copenhagen, Aarhus N, Odense
2025-02-13
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Aalborg, Aarhus N, Copenhagen, Odense C
2025-01-30
Recruiting
University of Aarhus
Not applicable
218
Aarhus N
2025-01-28
Recruiting
Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy
NCT06425666Cataract Surgery, Cataract and Fuchs Endothelial Corneal Dystrophy
University of Cologne
Not applicable
120
Aarhus N
2025-01-24
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Aarhus N, Esbjerg, Glostrup Municipality
2025-01-13
Recruiting
Janssen Research & Development, LLC
Phase 3
750
Aarhus N, Esbjerg, Frederiksberg, Herning, Svendborg, Vejle
2025-01-09
Active, closed
Amgen
Phase 3
707
Aarhus N, Vejle
2024-12-09
Active, closed
Hoffmann-La Roche
Phase 2
62
Aalborg, Aarhus N, Herlev
2024-12-09
Recruiting
Aarhus University Hospital
Not applicable
84
Aarhus N
2024-12-06
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Aarhus N, København Ø, Odense C
2024-12-03
Recruiting
GlaxoSmithKline
Phase 3
750
Aarhus N, Copenhagen, Hvidovre, Odense C
2024-11-26
Recruiting
Trial Designs for Evaluating Migraine Treatment
NCT06617832Migraine With Aura, Migraine Without Aura, Headache, Migraine
University of Aarhus
Not applicable
128
Aarhus C, Aarhus N
2024-11-13
Not yet open
Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy
NCT06623903Early Breast Cancer, Metabolic Health, Estrogen Receptor Positive Breast Cancer
Aarhus University Hospital
Observational
112
Aarhus N
2024-11-01
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Aarhus N
2024-10-29
Recruiting
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
NCT07026539Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease Due to Type 2 Diabetes Mellitus, Cardiovascular Diseases
DrugFinerenone
University of Aarhus
Phase 4
80
Aarhus N
2024-10-23
Recruiting
D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis
NCT06909409Idiopathic Pulmonary Fibrosis (IPF)
University of Aarhus
Observational
120
Aarhus N
2024-10-11
Active, closed
The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic Proctosigmoiditis
NCT07061899Proctitis, Ulcerative, Sexually Transmitted Disease (STD), Ulcerative Proctosigmoiditis
University of Aarhus
Observational
214
Aarhus N, Herning, Randers, Silkeborg, Viborg
2024-10-01
Active, closed
Hoffmann-La Roche
Phase 3
338
Aarhus N, Herlev, Herning
2024-09-23
Active, closed
argenx
Phase 3
141
Aarhus N, Copenhagen
2024-09-18
Recruiting
Left Bundle Branch Area Pacing or Biventricular Pacing in AF and Left Ventricular Dysfunction
NCT06620705Heart Failure, Block, Heart, Pacing-Induced Cardiomyopathy
srdpiers
Not applicable
34
Aarhus N
2024-09-10
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Aarhus N
2024-09-04
Recruiting
Bayer
Phase 3
444
Copenhagen, Aarhus N, Herning, Aalborg, Odense
2024-08-28
Recruiting
Aarhus University Hospital
Phase 1
30
Aarhus N
2024-08-26
Recruiting
Danish Vulva Cancer Recurrence Study
NCT06495554Vulva Cancer, Vulva Neoplasm, Vulvar Cancer, Vulva Disease
University of Aarhus
Not applicable
1,295
Aarhus N, Copenhagen
2024-08-15
Active, closed
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
DrugsIptacopan·Rituximab
Novartis Pharmaceuticals
Phase 2
84
Aarhus N, Herlev
2024-08-05
Recruiting
Amgen
Phase 3
450
Aalborg, Aarhus N, Copenhagen, Odense C
2024-07-17
Active, closed
Celldex Therapeutics
Phase 3
963
Aarhus N, Copenhagen NV, Hellerup
2024-07-11
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Hellerup, Aalborg, Aarhus N, Gistrup, Hillerød, København Ø, Odense C, Svendborg
2024-06-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Herlev, Aarhus N, Aalborg, Odense C, Sønderborg, Vejle
2024-06-24
Recruiting
AstraZeneca
Phase 3
240
Aarhus N, Copenhagen, Odense C
2024-06-20
Active, closed
Hoffmann-La Roche
Phase 2
256
Aarhus N, Koebenhavn Oe
2024-05-02
Recruiting
University of Aarhus
Not applicable
150
Aarhus C, Aarhus N
2024-05-01
By invitation
Aarhus University Hospital
Observational
200
Aarhus N
2024-04-30
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Aarhus N
2024-04-22
Recruiting
University of Aarhus
Observational
100
Aalborg, Aarhus N, Copenhagen, Odense
2024-04-11
Recruiting
Aarhus University Hospital
Phase 1/2
80
Aarhus N
2024-03-07
Active, closed
Aarhus University Hospital
Observational
65
Aarhus, Aarhus N
2024-03-01
Active, closed
Medial Patellofemoral Ligament Reconstruction in Children - a 2-8 Years Follow-up Study
NCT06257836Medial Patellofemoral Dislocation, Medial Patellofemoral Ligament Reconstruction
Aarhus University Hospital
Observational
160
Aarhus N
2024-03-01
Active, closed
Aarhus University Hospital
Observational
130
Aarhus N
2024-03-01
Recruiting
Nordic Randomized Trial on Laparoscopic Versus Vaginal Cerclage
NCT06122506Preterm Birth, Cervical Insufficiency
University of Aarhus
Not applicable
188
Aarhus N, Copenhagen
2024-01-31
Recruiting
FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis
NCT06206707Diarrhea, Colitis, Malignant Melanoma, Kidney Cancer
University of Aarhus
Not applicable
20
Aarhus N
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Aarhus N, Hvidovre
2024-01-19
Recruiting
Odense University Hospital
Not applicable
80
Aarhus N, Odense C
2024-01-09
Recruiting
Lymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome
NCT06325618Turner Syndrome, Cardiovascular Diseases, Lymphedema, Inflammation
DrugIndocyanine Green
University of Aarhus
Observational
150
Aarhus N
2024-01-08
Recruiting
Copenhagen University Hospital at Herlev
Observational
500
Aarhus N, Copenhagen Ø, Herlev
2024-01-01
Recruiting
Janssen-Cilag Ltd.
Observational
900
Aalborg, Aarhus N, Copenhagen, Odense, Vejle
2023-12-18
Recruiting
Amgen
Phase 3
750
Aarhus N, Copenhagen, Herning, Sønderborg, Vejle
2023-11-16
Active, closed
AstraZeneca
Phase 3
863
Aarhus N, Copenhagen
2023-11-09
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Aalborg, Aarhus N, Herlev, Hillerød, Næstved, Sønderborg
2023-10-24
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Aarhus N, Copenhagen
2023-10-02
Recruiting
AstraZeneca
Phase 3
800
Aarhus N, København Ø, Odense
2023-09-22
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Aalborg, Aarhus N, Herning
2023-09-18
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Aarhus N, Odense C
2023-09-13
Recruiting
Remote Ischemic Conditioning in Aneurysmal SAH
NCT06032533Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia
Aarhus University Hospital
Not applicable
100
Aarhus N
2023-09-09
Recruiting
Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.
NCT05834803Renovascular Hypertension, Renovascular Hypertension With Renal Failure, Heart Failure, Renal Artery Stenosis Atherosclerotic
University of Aarhus
Not applicable
80
Aarhus N, Copenhagen, Odense C
2023-06-26
By invitation
University of Aarhus
Observational
500
Aarhus N
2023-06-01
Active, closed
Hoffmann-La Roche
Phase 2
204
Aarhus N, Herlev
2023-04-13
Active, closed
Bayer
Phase 3
985
Aarhus N, Aalborg, Næstved, København Ø
2023-04-03
By invitation
The Nordic Rectal Prolapse Study
NCT05569980Rectal Prolapse, Surgery, Recurrence, Quality of Life
Aarhus University Hospital
Observational
430
Aarhus N
2023-04-01
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Aarhus N, Copenhagen S, Esbjerg, Gandrup, Herlev, Herning, Kobenhavn N V, Roskilde
2023-03-09
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Herlev, Aarhus N, Holbæk, Svendborg, Herning, Hillerød, Kolding, Slagelse
2023-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
213
Aarhus N
2022-12-15
Active, closed
Amgen
Phase 3
7,297
Aalborg, Aarhus N, Copenhagen O, Esbjerg, Gandrup, Herlev, Herning, Holbæk
2022-12-14
Recruiting
AstraZeneca
Phase 3
3,527
Aalborg, Aarhus N, Copenhagen, Copenhagen Ø, Herning, Hillerød, Hvidovre, Kolding
2022-12-13
Recruiting
Pfizer
Phase 3
100
Aarhus N, Copenhagen
2022-12-09
Active, closed
University of Aarhus
Not applicable
84
Aarhus, Aarhus N, Copenhagen, Hellerup, Herning, Odense, Silkeborg, Vejle
2022-11-25
Recruiting
Bayer
Phase 3
100
Copenhagen, Aarhus N, Odense
2022-11-08
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Køge, Esbjerg, Aarhus N, Hellerup, Hvidovre
2022-11-01
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Aarhus N, Hellerup, Odense C
2022-09-06
Recruiting
Morten Steen Kvistholm Jensen
Phase 4
100
Aarhus N, Odense, Roskilde, Viborg
2022-08-10
Recruiting
Danish Prostate Cancer Consortium Study-1
NCT05767307Prostate Cancer
Aarhus University Hospital
Observational
2,500
Aarhus N, Hellerup, Odense
2022-08-01
Recruiting
Aarhus University Hospital
Not applicable
60
Aarhus N
2022-04-01
Active, closed
Bayer
Phase 3
219
Copenhagen, Aarhus N, Odense
2022-03-28
Active, closed
Hoffmann-La Roche
Phase 2
46
Aarhus N
2022-03-22
Active, closed
Thyroid Nodule Gene Sequencing in a Danish Population
NCT05377736Thyroid Nodule (Diagnosis), Thyroid Cancer
Aarhus University Hospital
Not applicable
30
Aarhus N
2022-03-01
Active, closed
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
NCT05185258Psoriasis Vulgaris, Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous
Aarhus University Hospital
Phase 4
12
Aarhus N
2022-02-16
By invitation
Aarhus University Hospital
Observational
2,000
Aarhus N, Gødstrup, Horsens, Randers, Viborg
2022-01-01
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Aalborg, Aarhus N, Copenhagen, Odense
2021-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Herning, Aarhus N, Esbjerg, Glostrup Municipality, Herlev, Hjørring, Roskilde, Svendborg
2021-11-23
Active, closed
Amgen
Phase 3
303
Aalborg, Aarhus N, København Ø, Odense
2021-11-02
Active, closed
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386Amyloid Cardiomyopathy, Transthyretin-Related
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
389
Aarhus N
2021-10-27
Recruiting
Karen-Lise Garm Spindler
Phase 2
350
Aarhus N, Vejle
2021-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Aalborg, Aarhus N, Copenhagen, Odense, Vejle
2021-10-14
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Aarhus N, Copenhagen
2021-10-06
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Aalborg, Aarhus N, Copenhagen, Odense C
2021-09-20
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Aarhus N, Copenhagen, Odense C
2021-08-19
Recruiting
University of Aarhus
Phase 2
55
Aarhus N
2021-07-07
Recruiting
University of Aarhus
Not applicable
102
Aarhus N, Esbjerg, Farsø, Silkeborg, Viborg
2021-05-28
Active, closed
AstraZeneca
Phase 3
893
Aalborg, Aarhus N, Hillerød, Odense
2021-05-10
Recruiting
University of Aarhus
Not applicable
200
Aarhus N, Silkeborg
2021-04-16
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Aarhus N, Odense C
2021-04-08
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Aarhus N, Aalborg, Roskilde, Odense C
2021-04-05
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Aarhus N, Hvidovre, København NV, Odense C
2021-04-01
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Aarhus N, Aalborg
2021-03-11
Active, closed
Hoffmann-La Roche
Phase 3
270
Aarhus N, København Ø
2021-02-23
Recruiting
Mechanism of Sarcopenia in Heart Failure
NCT05063955Heart Failure, Sarcopenia, Cachexia
Aarhus University Hospital
Observational
250
Aarhus N
2020-12-02
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Aalborg, Aarhus N, Copenhagen N, Herlev
2020-11-12
Recruiting
Aarhus University Hospital
Observational
30
Aarhus N
2020-11-01
Active, closed
Hoffmann-La Roche
Phase 3
985
Aarhus N, Glostrup Municipality
2020-10-26
Recruiting
Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
NCT04699734Painful Diabetic Neuropathy, Neuropathic Pain, Neuropathy;Peripheral
University of Aarhus
Not applicable
16
Aarhus N
2020-09-08
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
Aalborg, Aarhus N, Copenhagen, Roskilde
2020-08-20
Recruiting
Aarhus University Hospital
Observational
400
Aarhus N
2020-08-15
Active, closed
Sanofi
Phase 3
337
Aalborg, Aarhus N, Copenhagen, Roskilde
2020-06-16
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Aalborg, Aarhus N
2020-03-30
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Odense, Aarhus N
2019-11-26
Active, closed
Bristol-Myers Squibb
Phase 3
790
Aarhus N, Herlev, Odense
2019-10-28
Active, closed
Novo Nordisk A/S
Phase 3
134
Aarhus N
2019-10-21
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
Aarhus N
2019-10-09
Active, closed
AstraZeneca
Phase 4
75
Aalborg, Aarhus N, Copenhagen, Hvidovre, Næstved, Odense C, Vejle
2019-10-08
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Aarhus N, København Ø, Odense C
2019-08-13
By invitation
Novo Nordisk A/S
Observational
60
Aarhus N
2019-04-01
Active, closed
AstraZeneca
Phase 3
1,407
Aalborg, Aarhus N, Odense, Roskilde, Vejle
2019-01-04
Recruiting
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NCT03563417Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery
Aarhus University Hospital Skejby
Not applicable
1,560
Aarhus N, Copenhagen, Hellerup, Odense, Roskilde
2018-11-06
Active, closed
Hoffmann-La Roche
Phase 3
927
Aarhus N, Glostrup Municipality, Sønderborg
2018-05-28
Active, closed
Hoffmann-La Roche
Phase 1/2
211
Aarhus N, København Ø, Odense C
2018-05-08
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Aarhus N, Herlev, Odense
2018-04-11
Active, closed
AbbVie
Phase 2
156
Copenhagen Ø, Aarhus N, Odense, Vejle
2018-04-02
Active, closed
Sanofi
Phase 3
475
Aalborg, Aarhus N, Odense C
2017-12-07
Active, closed
Aarhus University Hospital Skejby
Not applicable
1,201
Aalborg, Aarhus N, Gentofte Municipality, København Ø, Odense, Roskilde
2017-07-05
Active, closed
Aarhus University Hospital
Not applicable
90
Aarhus N
2017-07-01
Active, closed
SORT OUT X - Combo Stent Versus ORSIRO Stent
NCT03216733Coronary Heart Disease, Angina Pectoris, Myocardial Infarction
Aarhus University Hospital Skejby
Not applicable
3,148
Aalborg, Aarhus N, Copenhagen, Odense C
2017-06-01
Active, closed
Aarhus University Hospital Skejby
Not applicable
120
Aarhus N, Odense, Roskilde
2016-01
Active, closed
AbbVie
Phase 3
1,629
Aarhus N, Silkeborg
2015-12-01
Recruiting
A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
NCT02770066Renal Artery Obstruction, Hypertension, Renovascular, Cardiovascular Diseases, Kidney Diseases
University of Aarhus
Observational
160
Aalborg, Aarhus N, Glostrup Municipality, Holbæk, Odense C
2015-01-01
Active, closed
University of Aarhus
Not applicable
5,000
Aarhus N
2013-02
Rows per page Showing 1–205 of 205
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/aarhus-n

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 205 of those studies with a site in Aarhus N.

How many clinical trials are recruiting in Aarhus N?

115 of the 205 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 7 have not yet opened recruitment, 71 are active but closed to new participants, and 12 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Aarhus N), 205 studies
PhaseStudiesRecruitingShare
Phase 3883842.9%
Not applicable433121%
Observational322015.6%
Phase 220129.8%
Phase 41074.9%
Phase 1542.4%
Phase 1/2422%
Phase 2/3311.5%

Most active sponsors

Lead sponsors with the most studies (Aarhus N)
Lead sponsorStudiesRecruiting
University of Aarhus3930
Aarhus University Hospital2614
AstraZeneca1712
Hoffmann-La Roche164
Novo Nordisk A/S135
Novartis Pharmaceuticals114
Amgen84
Janssen Research & Development, LLC72
Aarhus University Hospital Skejby51
Bayer53
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.